The common cold arises from an acute viral infection of the upper respiratory tract and presents with cough, sputum, nasal congestion, and sore throat. It is generally a mild illness that resolves naturally without specific treatment, classifying it as a self‑limiting disease.
While the cold itself is usually benign, viral infections like COVID‑19 and seasonal influenza pose heightened concerns for high‑risk populations—including the elderly, infants, pregnant women, and patients with chronic conditions. In these groups, the infection can be accompanied by complications such as acute encephalitis or pneumonia, and fatal outcomes have been reported.
Tin tức hàng ngày1 thg 9, 2026•1 phút đọc
Common Cold: Symptoms, Self‑Limiting Course & Risks for Vulnerable
The common cold is a mild, self‑limiting upper respiratory viral infection; high‑risk groups may develop serious complications such as encephalitis or pneumonia.
Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: KPA News
Chủ đề:#common cold#viral infection#respiratory disease#high-risk patients#complications#public health
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bài viết khác
Xem tất cả bài viếtNghiên cứu & Báo cáo
Global Finished Dosage Manufacturing Landscape 2026
5 thg 10, 2026
Cập nhật pháp chếKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 thg 9, 2026
Phân tíchPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 thg 9, 2026
Để lại đánh giá